HUP0000564A2 - Olajos szuszpenzió alakú gyógyászati készítmények - Google Patents

Olajos szuszpenzió alakú gyógyászati készítmények

Info

Publication number
HUP0000564A2
HUP0000564A2 HU0000564A HUP0000564A HUP0000564A2 HU P0000564 A2 HUP0000564 A2 HU P0000564A2 HU 0000564 A HU0000564 A HU 0000564A HU P0000564 A HUP0000564 A HU P0000564A HU P0000564 A2 HUP0000564 A2 HU P0000564A2
Authority
HU
Hungary
Prior art keywords
pharmaceutical composition
oil suspension
ceftiofur
contain
formula
Prior art date
Application number
HU0000564A
Other languages
English (en)
Inventor
Todd P. Foster
David L. Kiefer
Original Assignee
Pharmacia And Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25194373&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0000564(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia And Upjohn Company filed Critical Pharmacia And Upjohn Company
Publication of HUP0000564A2 publication Critical patent/HUP0000564A2/hu
Publication of HUP0000564A3 publication Critical patent/HUP0000564A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány gyógyszerkészítményekre vonatkozik, amelyek gyógyszerhatóanyagok olajos szuszpenziójában kis mennyiségű vizet tartalmaznak,pl. a (II) képletű ceftiofur, különösen a ceftiofur hid- roklorid sójaesetében. Ó
HU0000564A 1996-12-09 1997-12-03 Pharmaceutical composition in form of oil suspension HUP0000564A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/806,584 US5736151A (en) 1996-12-09 1996-12-09 Antibiotic oil suspensions
PCT/US1997/021401 WO1998025621A1 (en) 1996-12-09 1997-12-03 Improved pharmaceutical compositions

Publications (2)

Publication Number Publication Date
HUP0000564A2 true HUP0000564A2 (hu) 2000-10-28
HUP0000564A3 HUP0000564A3 (en) 2001-01-29

Family

ID=25194373

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000564A HUP0000564A3 (en) 1996-12-09 1997-12-03 Pharmaceutical composition in form of oil suspension

Country Status (22)

Country Link
US (1) US5736151A (hu)
EP (1) EP0941095B1 (hu)
JP (1) JP2001505910A (hu)
KR (1) KR100544248B1 (hu)
CN (1) CN100413506C (hu)
AT (1) ATE264681T1 (hu)
AU (1) AU746666B2 (hu)
BR (1) BR9714967B1 (hu)
CA (1) CA2269682C (hu)
CZ (1) CZ297632B6 (hu)
DE (1) DE69728783T2 (hu)
DK (1) DK0941095T3 (hu)
ES (1) ES2218705T3 (hu)
FI (1) FI991302A0 (hu)
HK (1) HK1023292A1 (hu)
HU (1) HUP0000564A3 (hu)
NO (1) NO325475B1 (hu)
NZ (1) NZ336183A (hu)
PL (1) PL190662B1 (hu)
PT (1) PT941095E (hu)
SK (1) SK72399A3 (hu)
WO (1) WO1998025621A1 (hu)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7829100B2 (en) * 2000-09-12 2010-11-09 Teagarden Dirk L Pharmaceutical composition having modified carrier
CA2416566C (en) * 2000-09-12 2011-05-31 Pharmacia & Upjohn Company Depot formulation comprising ceftiofur and peroxidized natural oil
KR100423895B1 (ko) * 2001-02-19 2004-03-24 주식회사 엘지생명과학 셉티오퍼 하이드로클로라이드의 현탁제 조성물
US20040022815A1 (en) * 2002-08-05 2004-02-05 Orchid Health Care Novel pharmaceutical composition of ceftiofur
AU2002328168B2 (en) * 2002-08-07 2008-08-21 Merial Ltd. Novel pharmaceutical composition of ceftiofur
KR20040015622A (ko) * 2002-08-13 2004-02-19 대한뉴팜(주) 세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물
US7659061B2 (en) * 2002-11-19 2010-02-09 Pharmacia & Upjohn Company Pharmaceutical compositions having a modified vehicle
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
KR100717433B1 (ko) * 2003-03-20 2007-05-14 파마시아 코포레이션 소염제의 분산성 배합물
US20040214753A1 (en) * 2003-03-20 2004-10-28 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
WO2005009472A2 (en) * 2003-07-31 2005-02-03 Pharmacia & Upjohn Company Llc Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
WO2006008640A1 (en) * 2004-07-15 2006-01-26 Pharmacia & Upjohn Company Llc Non-aqueous suspension containing a drug having an unpleasant taste
CZ300424B6 (cs) * 2006-06-20 2009-05-13 Pliva - Lachema A. S. Farmaceutická kompozice pro perorální podání
CZ300590B6 (cs) * 2006-06-20 2009-06-24 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
CN101610754A (zh) * 2007-02-16 2009-12-23 Aska制药株式会社 含有微粒油性混悬液的药物组合物
CN101406447B (zh) * 2007-10-12 2010-08-25 河南农业大学 复方头孢噻呋油混悬注射液制备工艺
US20100087481A1 (en) * 2008-10-03 2010-04-08 Lee Kathleen M Oral pharmaceutical formulations for antidiabetic compounds
KR101748890B1 (ko) * 2008-11-19 2017-06-19 메리얼 인코포레이티드 세프티오퍼 및 케토프로펜 또는 세프티오퍼 및 벤질 알코올을 포함하는 제형
HUE046427T2 (hu) 2012-07-17 2020-03-30 Bayer New Zealand Ltd Injektálható antibiotikus készítmények és azok alkalmazása
FR3000392B1 (fr) 2012-12-27 2015-03-27 Virbac Nouvelles compositions pharmaceutiques veterinaires et leur procede de preparation
CN106456704A (zh) 2014-04-16 2017-02-22 Veyx-药物有限公司 兽药组合物和其应用
EP3267994A4 (en) 2015-03-09 2018-10-31 Intekrin Therapeutics, Inc. Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
WO2018071810A1 (en) 2016-10-13 2018-04-19 RhinoNase, Inc. Antibiotic compositions for nasal irrigation and methods
WO2018187350A1 (en) 2017-04-03 2018-10-11 Coherus Biosciences Inc. PPARγ AGONIST FOR TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY
CN113209015A (zh) * 2020-01-21 2021-08-06 江西邦诚动物药业有限公司 长效盐酸头孢噻呋混悬注射液及其制备工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB914894A (en) * 1960-08-12 1963-01-09 Beecham Res Lab Injectable pharmaceutical media
NL260648A (hu) * 1961-01-31
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
FR2479229B1 (fr) * 1980-03-26 1986-01-17 Clin Midy Nouveaux derives des cephalosporines, leur procede de preparation et les medicaments utilisables comme antibiotiques qui contiennent lesdits derives
US4902683A (en) * 1984-10-25 1990-02-20 The Upjohn Company Crystalline cephalosporin hydrohalide salts
EP0233255B1 (en) * 1985-08-12 1996-05-29 The Upjohn Company Conversion of cephalosporin hydrohalide salt to alkali metal salt
DE3887691T2 (de) * 1987-11-10 1994-06-09 Upjohn Co Cephalosporin-antibiotika.
US5223496A (en) * 1987-11-10 1993-06-29 The Upjohn Company Cephalosporin antibiotics
US4877782A (en) * 1988-02-16 1989-10-31 The Upjohn Company Zinc ceftiofur complexes
AU639004B2 (en) * 1989-06-13 1993-07-15 Abbott Laboratories Anhydrous oil-based liquid suspension for delivering a medicament
ATE202109T1 (de) * 1993-03-12 2001-06-15 Upjohn Co Kristallines ceftiofur (freie säure)

Also Published As

Publication number Publication date
FI991302A (fi) 1999-06-08
PT941095E (pt) 2004-08-31
CA2269682A1 (en) 1998-06-18
ES2218705T3 (es) 2004-11-16
NO992780D0 (no) 1999-06-08
NZ336183A (en) 2000-12-22
ATE264681T1 (de) 2004-05-15
BR9714967B1 (pt) 2010-06-29
AU5452998A (en) 1998-07-03
WO1998025621A1 (en) 1998-06-18
US5736151A (en) 1998-04-07
DK0941095T3 (da) 2004-08-02
PL190662B1 (pl) 2005-12-30
CA2269682C (en) 2009-04-14
DE69728783T2 (de) 2005-03-31
KR20000069360A (ko) 2000-11-25
NO992780L (no) 1999-06-08
EP0941095A1 (en) 1999-09-15
CN1238690A (zh) 1999-12-15
BR9714967A (pt) 2001-10-30
CZ297632B6 (cs) 2007-02-14
DE69728783D1 (de) 2004-05-27
CZ202599A3 (cs) 1999-09-15
FI991302A0 (fi) 1999-06-08
AU746666B2 (en) 2002-05-02
NO325475B1 (no) 2008-05-13
KR100544248B1 (ko) 2006-01-23
HUP0000564A3 (en) 2001-01-29
CN100413506C (zh) 2008-08-27
SK72399A3 (en) 2000-05-16
EP0941095B1 (en) 2004-04-21
JP2001505910A (ja) 2001-05-08
HK1023292A1 (en) 2000-09-08

Similar Documents

Publication Publication Date Title
HUP0000564A2 (hu) Olajos szuszpenzió alakú gyógyászati készítmények
NO20006323L (no) Glykopeptid-derivater og farmasöytiske sammensetninger som inneholder disse
YU49315B (sh) Inhibitor protein kinaze c, njegove farmaceutske formulacije i postupak za dobijanje
BR9915822B1 (pt) derivados de pirazolopirimidinona e sua composição farmacêutica para o tratamento de impotência
DE60112609D1 (en) Pyrazolopyridine
EA199900373A2 (ru) Фармацевтические композиции
TNSN99126A1 (fr) Pyrrolopyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
ES2184266T3 (es) Preparacion enzimatica liquida y su empleo.
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
DE60009511D1 (de) Nematizide trifluorbutene
NO20034230L (no) 1,2,3,4-tetrahydroisokinolin-derivater som urotensin II reseptor-antagonister
ATE300541T1 (de) Pyrazolopyridinderivate
MXPA03006224A (es) Inhibidores de cruzipaina y otras proteasas de cisteina.
NO306020B1 (no) N-alkylthiopolyaminderivater som radiobeskyttende midler
HUP0402077A2 (hu) Fungicid hatóanyag-kombinációk
ATE311388T1 (de) Pyrimidotriazine als phosphataseinhibitoren
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
DK1307445T3 (da) Benzofuranderivater og deres anvendelse som antibakterielle midler
TNSN99146A1 (fr) Derives de 1-heteroaryl-pyrrolidine, -piperidine et - homopiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
ES2091039T3 (es) Nuevos bis-fenil-hexenos.
PT100001A (pt) Novos derivados glicosilicos inibidores da gluco-hidrolase uteis como agentes antidiabeticos
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso
ATE345778T1 (de) (ester)-lysolecithine in liposomen

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished